Share:
Share this content in WeChat
X
Review
Research advances in the potential association between the glymphatic system and pain mechanisms and its assessment by MRI
MAO Jiaojiao  YANG Wei  LIU Yuqing  QIU Zhiqiang  XU Xiaoxue 

Cite this article as MAO J J, YANG W, LIU Y Q, et al. Research advances in the potential association between the glymphatic system and pain mechanisms and its assessment by MRI[J]. Chin J Magn Reson Imaging, 2026, 17(6): 162-172. DOI:10.12015/issn.1674-8034.2026.06.021.


[Abstract] The glymphatic system (GS) is a crucial pathway for interstitial fluid drainage and waste clearance in the central nervous system, playing a key role in removing metabolic byproducts from the brain and maintaining neuronal microenvironment homeostasis. In recent years, advances in MRI have enabled in vivo assessment of the GS. Previous studies have demonstrated that GS dysfunction is associated not only with neurodegenerative diseases and cerebral small vessel disease, but also potentially with the development and persistence of certain pain conditions. However, due to the limited number of studies investigating GS functional alterations in pain states, a unified understanding of the underlying mechanisms remains lacking. Therefore, this article aims to elucidate the structural and functional mechanisms of the GS from the perspective of the brain's metabolic waste clearance axis, and to explore the potential pathways through which pain may influence different components of this system. In addition, it summarizes recent advances in the application of various MRI techniques for evaluating the GS and related structures, and reviews imaging evidence across different pain conditions. Finally, the limitations and future directions of the current research are summarized and discussed, with the aim of providing new insights into pain mechanism research and imaging evaluation.
[Keywords] glymphatic system;pain;magnetic resonance imaging;multimodal magnetic resonance imaging;diffusion magnetic resonance imaging

MAO Jiaojiao   YANG Wei   LIU Yuqing   QIU Zhiqiang   XU Xiaoxue*  

Department of Radiology, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China

Corresponding author: XU X X, E-mail: nclittlesnownc@163.com

Conflicts of interest   None.

Received  2026-03-23
Accepted  2026-05-25
DOI: 10.12015/issn.1674-8034.2026.06.021
Cite this article as MAO J J, YANG W, LIU Y Q, et al. Research advances in the potential association between the glymphatic system and pain mechanisms and its assessment by MRI[J]. Chin J Magn Reson Imaging, 2026, 17(6): 162-172. DOI:10.12015/issn.1674-8034.2026.06.021.

[1]
COHEN S P, VASE L, HOOTEN W M. Chronic pain: an update on burden, best practices, and new advances[J]. Lancet, 2021, 397(10289): 2082-2097. DOI: 10.1016/S0140-6736(21)00393-7.
[2]
FALASINNU T, HOSSAIN M B, WEBER K A N, et al. The problem of pain in the United States: a population-based characterization of biopsychosocial correlates of high impact chronic pain using the National Health Interview Survey[J]. J Pain, 2023, 24(6): 1094-1103. DOI: 10.1016/j.jpain.2023.03.008.
[3]
DENG M, FANG Y, CHU Y, et al. SIRT3 is required for the protective function of ketogenic diet on neural inflammation and neuropathic pain[J]. Int J Biol Sci, 2025, 21(7): 3011-3029. DOI: 10.7150/ijbs.110921.
[4]
SU P Y P, ZHANG L, HE L, et al. The role of neuro-immune interactions in chronic pain: implications for clinical practice[J]. J Pain Res, 2022, 15: 2223-2248. DOI: 10.2147/JPR.S246883.
[5]
MCKENZIE A, DOMBROWER R, THEERAPHAPPHONG N, et al. Glial activation, neuroinflammation, and loss of neuroprotection in chronic pain: cellular mechanisms and emerging therapeutic strategies[J/OL]. Biomedicines, 2026, 14(1): 58 [2026-03-23]. https://www.mdpi.com/2227-9059/14/1/58. DOI: 10.3390/biomedicines14010058.
[6]
MA Y C, KANG Z B A O, SHI Y Q, et al. The complexity of neuropathic pain and central sensitization: exploring mechanisms and therapeutic prospects[J/OL]. J Integr Neurosci, 2024, 23(5): 89 [2026-03-23]. https://www.imrpress.com/journal/JIN/23/5/10.31083/j.jin2305089. DOI: 10.31083/j.jin2305089.
[7]
MONCADA M A A, TAMAYO M A N, ENCINAS M A N, et al. Immuno-inflammatory mechanisms in the chronification of pain[J]. Pain Ther, 2026, 15(2): 443-464. DOI: 10.1007/s40122-026-00818-x.
[8]
ZOU K, DENG Q, ZHANG H, et al. Glymphatic system: a gateway for neuroinflammation[J]. Neural Regen Res, 2024, 19(12): 2661-2672. DOI: 10.4103/1673-5374.391312.
[9]
DENG S, HU Y, CHEN S, et al. Chronic sleep fragmentation impairs brain interstitial clearance in young wildtype mice[J]. J Cereb Blood Flow Metab, 2024, 44(9): 1515-1531. DOI: 10.1177/0271678X241230188.
[10]
ASTARA K, TSIMPOLIS A, KALAFATAKIS K, et al. Sleep disorders and Alzheimer's disease pathophysiology: the role of the glymphatic system. A scoping review[J/OL]. Mech Ageing Dev, 2024, 217: 111899 [2026-03-23]. https://doi.org/10.1016/j.mad.2023.111899. DOI: 10.1016/j.mad.2023.111899.
[11]
TAHA B, MCGOVERN R, LAM C. A synthesized view of the CSF-blood barrier and its surgical implications for aging disorders[J/OL]. Front Aging Neurosci, 2024, 16: 1492449 [2026-03-23]. https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2024.1492449/full. DOI: 10.3389/fnagi.2024.1492449.
[12]
MUNICIO C, CARRERO L, ANTEQUERA D, et al. Choroid plexus aquaporins in CSF homeostasis and the glymphatic system: their relevance for Alzheimer's disease[J/OL]. Int J Mol Sci, 2023, 24(1): 878 [2026-03-23]. https://www.mdpi.com/1422-0067/24/1/878. DOI: 10.3390/ijms24010878.
[13]
DEFFNER F, GLEISER C, MATTHEUS U, et al. Aquaporin-4 expression in the human choroid plexus[J/OL]. Cell Mol Life Sci, 2022, 79(2): 90 [2026-03-23]. https://doi.org/10.1007/s00018-022-04136-1. DOI: 10.1007/s00018-022-04136-1.
[14]
ILIFF J J, WANG M, LIAO Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β[J/OL]. Sci Transl Med, 2012, 4(147): 147ra111 [2026-03-23]. https://doi.org/10.1126/scitranslmed.3003748. DOI: 10.1126/scitranslmed.3003748.
[15]
LOUVEAU A, SMIRNOV I, KEYES T J, et al. Structural and functional features of central nervous system lymphatic vessels[J]. Nature, 2015, 523(7560): 337-341. DOI: 10.1038/nature14432.
[16]
ASPELUND A, ANTILA S, PROULX S T, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules[J]. J Exp Med, 2015, 212(7): 991-999. DOI: 10.1084/jem.20142290.
[17]
ROSENSTRÖM A H C, KONSMAN J P, KOSEK E. Cytokines in cerebrospinal fluid and chronic pain in humans: past, present, and future[J]. Neuroimmunomodulation, 2024, 31(1): 157-172. DOI: 10.1159/000540324.
[18]
BÄCKRYD E, TANUM L, LIND A L, et al. Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma[J]. J Pain Res, 2017, 10: 515-525. DOI: 10.2147/JPR.S128508.
[19]
LOGGIA M L. "Neuroinflammation": does it have a role in chronic pain? Evidence from human imaging[J]. Pain, 2024, 165(11S): S58-S67. DOI: 10.1097/j.pain.0000000000003342.
[20]
XU H, LOTFY P, GELB S, et al. The choroid plexus synergizes with immune cells during neuroinflammation[J]. Cell, 2024, 187(18): 4946-4963. DOI: 10.1016/j.cell.2024.07.002.
[21]
ROBERT S M, REEVES B C, KIZILTUG E, et al. The choroid plexus links innate immunity to CSF dysregulation in hydrocephalus[J]. Cell, 2023, 186(4): 764-785. DOI: 10.1016/j.cell.2023.01.017.
[22]
MASSOUD A T, NOLTENSMEYER D A, Juranek J, et al. Insights into the role of the glymphatic system in the pathogenesis of post-hemorrhagic hydrocephalus[J]. Mol Neurobiol, 2025, 62(5): 6537-6543. DOI: 10.1007/s12035-025-04692-0.
[23]
TREFFY R W, ERAKY A M, HUSSAIN O, et al. Glymphatics for the neurosurgeon[J/OL]. Neurosurg Pract, 2023, 4(3): e00051 [2026-03-23]. https://doi.org/10.1227/neuprac.0000000000000051. DOI: 10.1227/neuprac.0000000000000051.
[24]
CHEN C, ZHU B, LUO W, et al. Trifluoperazine improves postoperative cognition by influencing astrocyte endfoot morphology and aquaporin-4 polarity[J]. Mol Neurobiol, 2025, 62(10): 12574-12587. DOI: 10.1007/s12035-025-05072-4.
[25]
HUANG H, LIN L, WU T, et al. Phosphorylation of AQP4 by LRRK2 R1441G impairs glymphatic clearance of IFNγ and aggravates dopaminergic neurodegeneration[J/OL]. NPJ Parkinsons Dis, 2024, 10(1): 31 [2026-03-23]. https://doi.org/10.1038/s41531-024-00643-z. DOI: 10.1038/s41531-024-00643-z.
[26]
KUBÍČKOVÁ L, KLUSÁKOVÁ I, DUBOVÝ P. Bilateral activation of glial cells and cellular distribution of the chemokine CCL2 and its receptor CCR2 in the trigeminal subnucleus caudalis of trigeminal neuropathic pain model[J]. Histochem Cell Biol, 2020, 153(4): 239-255. DOI: 10.1007/s00418-020-01850-4.
[27]
KONG Y, WU J, SUN X, et al. TGF-β1 modulates PFC glial cell activation to facilitate exercise-induced analgesia in mice with spared nerve injury[J]. IBRO Neurosci Rep, 2026, 20: 531-539. DOI: 10.1016/j.ibneur.2026.03.009.
[28]
CHOI S, KIM K, KWON M, et al. Modulation of neuropathic pain by glial regulation in the insular cortex of rats[J/OL]. Front Mol Neurosci, 2022, 15: 815945 [2026-03-23]. https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.815945/full. DOI: 10.3389/fnmol.2022.815945.
[29]
MUSSETTO V, MOEN A, TROFIMOVA L, et al. Differential activation of spinal and parabrachial glial cells in a neuropathic pain model[J/OL]. Front Cell Neurosci, 2023, 17: 1163171 [2026-03-23]. https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2023.1163171/full. DOI: 10.3389/fncel.2023.1163171.
[30]
YANG J, CAO C, LIU J, et al. Dystrophin 71 deficiency causes impaired aquaporin-4 polarization contributing to glymphatic dysfunction and brain edema in cerebral ischemia[J/OL]. Neurobiol Dis, 2024, 199: 106586 [2026-03-23]. https://doi.org/10.1016/j.nbd.2024.106586. DOI: 10.1016/j.nbd.2024.106586.
[31]
LI K, LIU Y, GONG J, et al. Reactive astrocyte-derived exosomes enhance intracranial lymphatic drainage in mice after intracranial hemorrhage[J/OL]. Fluids Barriers CNS, 2025, 22(1): 37 [2026-03-23]. https://doi.org/10.1186/s12987-025-00651-y. DOI: 10.1186/s12987-025-00651-y.
[32]
LIU H, MENG L, WANG J, et al. Enlarged perivascular spaces in alcohol-related brain damage induced by dyslipidemia[J]. J Cereb Blood Flow Metab, 2024, 44(10): 1867-1880. DOI: 10.1177/0271678X241251570.
[33]
SCHWERIN S C, BREEHL N, OBASA A, et al. Actigraphic evidence of persistent sleep disruption following repetitive mild traumatic brain injury in a gyrencephalic model[J]. Cereb Cortex, 2023, 33(15): 9263-9279. DOI: 10.1093/cercor/bhad199.
[34]
HUANG W, ZHANG Y, ZHOU Y, et al. Glymphatic dysfunction in migraine mice model[J]. Neuroscience, 2023, 528: 64-74. DOI: 10.1016/j.neuroscience.2023.07.027.
[35]
MING Z, LIU Y, JIA S, et al. Oxymatrine alleviates symptoms in high-fat diet and STZ-induced SD rats with painful diabetic neuropathy by reducing inflammation and oxidative stress[J/OL]. Front Immunol, 2026, 17: 1750051 [2026-03-23]. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1750051/full. DOI: 10.3389/fimmu.2026.1750051.
[36]
MCLEOD G A, JOSEPHSON C B, ENGBERS J D T, et al. Mapping the migraine: intracranial recording of cortical spreading depression in migraine with aura[J]. Headache, 2025, 65(4): 658-665. DOI: 10.1111/head.14907.
[37]
SCHAIN A J, MELO-CARRILLO A, STRASSMAN A M, et al. Cortical spreading depression closes paravascular space and impairs glymphatic flow: implications for migraine headache[J]. J Neurosci, 2017, 37(11): 2904-2915. DOI: 10.1523/JNEUROSCI.3390-16.2017.
[38]
ROSIC A B, DUKEFOSS D B, ÅBJØRSBRÅTEN K S, et al. Aquaporin-4-independent volume dynamics of astroglial endfeet during cortical spreading depression[J]. Glia, 2019, 67(6): 1113-1121. DOI: 10.1002/glia.23604.
[39]
YANG M F, REN D X, PAN X, et al. The role of astrocytes in migraine with cortical spreading depression: protagonists or bystanders? A narrative review[J]. Pain Ther, 2024, 13(4): 679-690. DOI: 10.1007/s40122-024-00610-9.
[40]
MAI C L, TAN Z, XU Y N, et al. CXCL12-mediated monocyte transmigration into brain perivascular space leads to neuroinflammation and memory deficit in neuropathic pain[J]. Theranostics, 2021, 11(3): 1059-1078. DOI: 10.7150/thno.44364.
[41]
ALABBAD S, FIGUEREDO N, YUAN H, et al. Developments in targeting calcitonin gene-related peptide[J]. Expert Rev Neurother, 2024, 24(5): 477-485. DOI: 10.1080/14737175.2024.2332754.
[42]
SCHOU W S, ASHINA S, AMIN F M, et al. Calcitonin gene-related peptide and pain: a systematic review[J/OL]. J Headache Pain, 2017, 18(1): 34 [2026-03-23]. https://doi.org/10.1186/s10194-017-0741-2. DOI: 10.1186/s10194-017-0741-2.
[43]
THOMAS J L, SCHINDLER E A, GOTTSCHALK C. Meningeal lymphatic vessel dysfunction driven by CGRP signaling causes migraine-like pain in mice[J/OL]. J Clin Invest, 2024, 134(15): e182556 [2026-03-23]. https://doi.org/10.1172/JCI182556. DOI: 10.1172/JCI182556.
[44]
NELSON-MANEY N P, BÁLINT L, BEESON A L S, et al. Meningeal lymphatic CGRP signaling governs pain via cerebrospinal fluid efflux and neuroinflammation in migraine models[J/OL]. J Clin Invest, 2024, 134(15): e175616 [2026-03-23]. https://doi.org/10.1172/JCI175616. DOI: 10.1172/JCI175616.
[45]
JEONG S H, PARK C J, CHA J, et al. Choroid plexus volume, amyloid burden, and cognition in the Alzheimer's disease continuum[J]. Aging Dis, 2024, 16(1): 552-564. DOI: 10.14336/AD.2024.0118.
[46]
DIEZ-CIRARDA M, YUS-FUERTES M, DELGADO-ALONSO C, et al. Choroid plexus volume is enlarged in long COVID and associated with cognitive and brain changes[J]. Mol Psychiatry, 2025, 30(7): 2821-2830. DOI: 10.1038/s41380-024-02886-x.
[47]
SUN Z, LI C, MUCCIO M, et al. Vascular aging in the choroid plexus: a 7 T ultrasmall superparamagnetic iron oxide (USPIO)-MRI study[J]. J Magn Reson Imaging, 2024, 60(6): 2564-2575. DOI: 10.1002/jmri.29381.
[48]
XU X, YANG X, ZHANG J, et al. Choroid plexus free-water correlates with glymphatic function in Alzheimer's disease[J/OL]. Alzheimers Dement, 2025, 21(5): e70239 [2026-03-23]. https://doi.org/10.1002/alz.70239. DOI: 10.1002/alz.70239.
[49]
LIU Z, SHOU Q, JANN K, et al. A test-retest study of single- and multi-delay pCASL for choroid plexus perfusion imaging in healthy subjects aged 19 to 87 years[J/OL]. Neuroimage, 2025, 308: 121048 [2026-03-23]. https://doi.org/10.1016/j.neuroimage.2025.121048. DOI: 10.1016/j.neuroimage.2025.121048.
[50]
EVANS P G, SOKOLSKA M, ALVES A, et al. Non-invasive MRI of blood-cerebrospinal fluid barrier function[J/OL]. Nat Commun, 2020, 11(1): 2081 [2026-03-23]. https://doi.org/10.1038/s41467-020-16002-4. DOI: 10.1038/s41467-020-16002-4.
[51]
WATANABE K, KUDO J, SASAKI M, et al. The influence of vascular risk factors and aging on choroid plexus enlargement[J]. Eur Radiol, 2026, 36(5): 3869-3878. DOI: 10.1007/s00330-025-12196-7.
[52]
DOČKAL T, HOUDEK P, SEMENOVYKH K, et al. Feeding regime synchronizes circadian clock in choroid plexus: insight into a complex mechanism[J/OL]. Cell Mol Life Sci, 2025, 82(1): 247 [2026-03-23]. https://doi.org/10.1007/s00018-025-05798-3. DOI: 10.1007/s00018-025-05798-3.
[53]
YANG L, KRESS B T, WEBER H J, et al. Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer[J/OL]. J Transl Med, 2013, 11: 107 [2026-03-23]. https://doi.org/10.1186/1479-5876-11-107. DOI: 10.1186/1479-5876-11-107.
[54]
ZHU Y, WANG G, KOLLURU C, et al. Transport pathways and kinetics of cerebrospinal fluid tracers in mouse brain observed by dynamic contrast-enhanced MRI[J/OL]. Sci Rep, 2023, 13(1): 13882 [2026-03-23]. https://doi.org/10.1038/s41598-023-40896-x. DOI: 10.1038/s41598-023-40896-x.
[55]
DAVIES J, SIEBENHANDL-WOLFF P, TRANQUART F, et al. Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration[J]. Arch Toxicol, 2022, 96(2): 403-429. DOI: 10.1007/s00204-021-03189-8.
[56]
BARISANO G, LYNCH K M, SIBILIA F, et al. Imaging perivascular space structure and function using brain MRI[J/OL]. Neuroimage, 2022, 257: 119329 [2026-03-23]. https://doi.org/10.1016/j.neuroimage.2022.119329. DOI: 10.1016/j.neuroimage.2022.119329.
[57]
MIRACLIN T A, RIMA S, VANJARE H A, et al. Cryptococcal choroid plexitis with trapped ventricle in an immunocompetent individual: an autopsy case with systematic review of reported cases[J/OL]. Am J Trop Med Hyg, 2026 [2026-03-23]. https://doi.org/10.4269/ajtmh.25-0614. DOI: 10.4269/ajtmh.25-0614.
[58]
LIU X, BARISANO G, SHAO X, et al. Cross-vendor test-retest validation of diffusion tensor image analysis along the perivascular space (DTI-ALPS) for evaluating glymphatic system function[J]. Aging Dis, 2024, 15(4): 1885-1898. DOI: 10.14336/AD.2023.0321-2.
[59]
TAOKA T, ITO R, NAKAMICHI R, et al. Diffusion tensor image analysis along the perivascular space (DTI-ALPS): revisiting the meaning and significance of the method[J]. Magn Reson Med Sci, 2024, 23(3): 268-290. DOI: 10.2463/mrms.rev.2023-0175.
[60]
BAO C, MA Y, LI M, et al. Assessment of glymphatic dysfunction in ulcerative colitis using DKI-ALPS: an innovative imaging biomarker[J/OL]. J Neuroradiol, 2026, 53(1): 101402 [2026-03-23]. https://doi.org/10.1016/j.neurad.2025.101402. DOI: 10.1016/j.neurad.2025.101402.
[61]
CAO Y, HUANG M, FU F, et al. Abnormally glymphatic system functional in patients with migraine: a diffusion kurtosis imaging study[J/OL]. J Headache Pain, 2024, 25(1): 118 [2026-03-23]. https://doi.org/10.1186/s10194-024-01825-z. DOI: 10.1186/s10194-024-01825-z.
[62]
SEPEHRBAND F, CABEEN R P, CHOUPAN J, et al. Perivascular space fluid contributes to diffusion tensor imaging changes in white matter[J]. Neuroimage, 2019, 197: 243-254. DOI: 10.1016/j.neuroimage.2019.04.070.
[63]
KIM D, HUANG Y, LIU J. Non-invasive MRI measurements of age-dependent in vivo human glymphatic exchange using magnetization transfer spin labeling[J/OL]. Neuroimage, 2025, 310: 121142 [2026-03-23]. https://doi.org/10.1016/j.neuroimage.2025.121142. DOI: 10.1016/j.neuroimage.2025.121142.
[64]
CHEN Z, LAI J H C, XU J, et al. The effect of aquaporin-4 inhibition on cerebrospinal fluid-tissue water exchange in mouse brain detected by magnetization transfer indirect spin labeling MRI[J/OL]. NMR Biomed, 2024, 37(7): e5093 [2026-03-23]. https://doi.org/10.1002/nbm.5093. DOI: 10.1002/nbm.5093.
[65]
FULTZ N E, BONMASSAR G, SETSOMPOP K, et al. Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep[J]. Science, 2019, 366(6465): 628-631. DOI: 10.1126/science.aax5440.
[66]
ROEFS E C A, EILING I, DE BRESSER J, et al. BOLD-CSF dynamics assessed using real-time phase contrast CSF flow interleaved with cortical BOLD MRI[J/OL]. Fluids Barriers CNS, 2024, 21(1): 107 [2026-03-23]. https://doi.org/10.1186/s12987-024-00607-8. DOI: 10.1186/s12987-024-00607-8.
[67]
WRIGHT A M, XU T, TONG Y, et al. HyPER: region-specific hypersampling of fMRI to resolve low-frequency, respiratory, and cardiac pulsations, revealing age-related differences[J/OL]. Neuroimage, 2025, 321: 121502 [2026-03-23]. https://doi.org/10.1016/j.neuroimage.2025.121502. DOI: 10.1016/j.neuroimage.2025.121502.
[68]
ORNELLO R, SALFI F, VITTORINI M G, et al. The potential role of sleep quality in the relationship between glymphatic function and migraine frequency: insights from a cross-sectional study[J/OL]. Headache, 2025 [2026-03-23]. https://doi.org/10.1111/head.15019. DOI: 10.1111/head.15019.
[69]
CAI X, SUN W, CAI M, et al. Impaired glymphatic function contributes to high-frequency attacks in patients with episodic migraine[J/OL]. J Headache Pain, 2025, 26(1): 132 [2026-03-23]. https://doi.org/10.1186/s10194-025-02070-8. DOI: 10.1186/s10194-025-02070-8.
[70]
YUAN Z, LI W, TANG H, et al. Enlarged perivascular spaces in patients with migraine: a case-control study based on 3 T MRI[J]. Ann Clin Transl Neurol, 2023, 10(7): 1160-1169. DOI: 10.1002/acn3.51798.
[71]
CHO J W, LEE G H, KIM J. Chronic migraine is associated with region-specific high-grade enlarged perivascular spaces: retrospective matched case-control study[J]. J Clin Neurol, 2026, 22(1): 113-121. DOI: 10.3988/jcn.2025.0271.
[72]
ZHANG X, WANG W, BAI X, et al. Increased glymphatic system activity in migraine chronification by diffusion tensor image analysis along the perivascular space[J/OL]. J Headache Pain, 2023, 24(1): 147 [2026-03-23]. https://doi.org/10.1186/s10194-023-01673-3. DOI: 10.1186/s10194-023-01673-3.
[73]
WU C A H, CHANG F C, WANG Y F, et al. Impaired glymphatic and meningeal lymphatic functions in patients with chronic migraine[J]. Ann Neurol, 2024, 95(3): 583-595. DOI: 10.1002/ana.26842.
[74]
REN X, WANG H, HE Y, et al. Impaired meningeal lymphatic drainage correlates with headache intensity in episodic migraine[J/OL]. J Headache Pain, 2025, 26(1): 265 [2026-03-23]. https://doi.org/10.1186/s10194-025-02211-z. DOI: 10.1186/s10194-025-02211-z.
[75]
XIONG J, LIU M, LI X, et al. Choroid plexus volume and association with migraine pathophysiology[J/OL]. Eur J Radiol, 2025, 188: 112135 [2026-03-23]. https://doi.org/10.1016/j.ejrad.2025.112135. DOI: 10.1016/j.ejrad.2025.112135.
[76]
LEE H J, LEE D A, PARK K M. Choroid plexus enlargement in patients with chronic migraine: implications for glymphatic system dysfunction[J]. Can J Neurol Sci, 2025: 1-7. DOI: 10.1017/cjn.2025.21.
[77]
WANG X, XIONG Y, LIU X, et al. Subcortical nuclei and glymphatic system alterations in migraine with aura: a comparative 7 T multimodal MRI analysis[J/OL]. J Headache Pain, 2025, 27(1): 22 [2026-03-23]. https://doi.org/10.1186/s10194-025-02258-y. DOI: 10.1186/s10194-025-02258-y.
[78]
HOU X, WU B, XU R, et al. Glymphatic dysfunction in classical trigeminal neuralgia: DTI-ALPS index stratification from healthy controls to post-MVD[J/OL]. J Headache Pain, 2025, 26(1): 148 [2026-03-23]. https://doi.org/10.1186/s10194-025-02064-6. DOI: 10.1186/s10194-025-02064-6.
[79]
CHEN F, ZHANG Z, MIAO J, et al. Glymphatic and neurofluidic dysfunction in classical trigeminal neuralgia: a multimodal MRI study of brain-CSF functional and structural dynamics[J/OL]. BMC Med Imaging, 2025, 25(1): 222 [2026-03-23]. https://doi.org/10.1186/s12880-025-01801-2. DOI: 10.1186/s12880-025-01801-2.
[80]
CHU T, XIONG F, GAO F, et al. Glymphatic dysfunction in trigeminal neuralgia: a multimodal MRI study[J/OL]. Neurobiol Dis, 2026, 220: 107312 [2026-03-23]. https://doi.org/10.1016/j.nbd.2026.107312. DOI: 10.1016/j.nbd.2026.107312.
[81]
WANG A, CHEN L, TIAN C, et al. Evaluation of the glymphatic system with diffusion tensor imaging-along the perivascular space in cancer pain[J/OL]. Front Neurosci, 2022, 16: 823701 [2026-03-23]. https://doi.org/10.3389/fnins.2022.823701. DOI: 10.3389/fnins.2022.823701.
[82]
TU Y, LI Z, XIONG F, et al. Decreased DTI-ALPS and choroid plexus enlargement in fibromyalgia: a preliminary multimodal MRI study[J]. Neuroradiology, 2023, 65(12): 1749-1755. DOI: 10.1007/s00234-023-03240-8.
[83]
VALDES-HERNANDEZ P A, MONTESINO-GOICOLEA S, NODARSE C L, et al. Widespread and prolonged pain may reduce brain clearance capacity only via sleep impairment: evidence from participants with knee pain[J/OL]. J Pain, 2025, 30: 105356 [2026-03-23]. https://doi.org/10.1016/j.jpain.2025.105356. DOI: 10.1016/j.jpain.2025.105356.
[84]
YANG J, LIU T, XIAO R, et al. Abnormal lymphatic system function in patients with chronic neck and shoulder pain: neuroimaging evidence from DTI-ALPS[J/OL]. Front Mol Neurosci, 2026, 19: 1707858 [2026-03-23]. https://doi.org/10.3389/fnmol.2026.1707858. DOI: 10.3389/fnmol.2026.1707858.

PREV Research progress of diffusion magnetic resonance imaging in the diagnosis of Alzheimer<sup><sup>,</sup></sup>s disease
NEXT Advances in the application of four-dimensional flow magnetic resonance imaging combined with computational fluid dynamics in vascular diseases
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn